<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>19080851</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Martín, M Carmen</dc:author>
<dc:author>Oliver, Javier</dc:author>
<dc:author>Mendoza, Juan Luis</dc:author>
<dc:author>Fernández-Arquero, Miguel</dc:author>
<dc:author>Urcelay, Elena</dc:author>
<dc:author>Martín, Javier</dc:author>
<dc:description xml:lang="en">BACKGROUND AND OBJECTIVE Inflammatory bowel disease (IBD) is a polygenic complex trait. The expression and presence in biopsiae from IBD patients points to a putative role of these genes in genetic susceptibility to IBD. This is the first association study on these genes in relation with IBD. PATIENTS AND METHOD Two polymorphisms were analyzed within F2R/PAR1 and another one mapping to F2RL1/PAR2 in 778 healthy controls and 943 IBD cases (Crohn's disease and ulcerative colitis patients from 2 cohorts from Madrid and Granada). RESULTS No significant differences in the distribution of the PARs' polymorphisms were found. CONCLUSIONS There is no evidence of association of the analyzed polymorphisms with IBD risk.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2008 Nov 08 </dc:date>
<dc:title xml:lang="es">Influencia de las mutaciones de los receptores activados por proteinasa F2R/PAR1 y F2RL1/PAR2 en la enfermedad inflamatoria intestinal.</dc:title>
<dc:title xml:lang="en">[Influence of mutations of proteinase-activated receptors F2R/PAR1 and F2RL1/PAR2 on inflammatory bowel disease].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
